World Varicose Vein Treatment Market to Reach USD 475 Mln by 2024, Projects Grand View Research in Its Report Available at MarketPublishers.com13 Sep 2016 • by Natalie Aster
LONDON – The value of the world market for varicose vein treatment is set to amount to USD 475 million by end-2024. The expanding technological advances in tandem with the growing availability of the cutting-edge devices to treat varicose veins and move towards minimally-invasive procedures are the factors boosting the market.
A range of factors such as the enormous burden of vascular diseases in the North America region and European countries and the growing patient compliance and reliability, a hike in healthcare spending, and the fast-paced increase in ageing population are propelling the expansion of the market for varicose vein procedures.
The rise of lifestyle disorders, like obesity, sleep disorders, hormonal changes, high blood pressure levels, genetic conditions and pregnancy are amongst the key factors causing peripheral vascular diseases (PVDs). Untreated venous insufficiency, like venous ulcers and varicose veins provoke progressive syndromes enclosing chronic venous insufficiency. Chronic venous insufficiency was widespread in 2015; it is the most typical disease globally and is anticipated to impact 5% of the population in the Western world.
In 2016, North America accounted for the lion’s market share owing to the soaring incidences of varicose and spider veins among people, favourable reimbursement policies, government expenditure, and the rising healthcare and aesthetic awareness across the region.
Vascular Solutions, Inc., Quanta Systems S.p.A, Lumenis Ltd., Eufoton S.R.L, Dornier MedTech GmbH, Energist Group, Medtronic plc, Biolitec AG, Syneron Medical Ltd., and AngioDynamics, Inc. are amid the dominant market participants.
In-demand research report “Varicose Vein Treatment Market Analysis” elaborated by Grand View Research presents a comprehensive review and assessment of the global varicose vein treatment marketplace.
The study provides granular market segmentation, gives estimates of the market size and growth prospects from 2013 and up to 2024 for the overall market. It presents an insightful look at the factors driving and restraining the sector’s growth, and casts light on the key opportunities for players. The report provides varicose vein treatment share by type, and offers market size estimates for each of individual market segment. It casts light on regional markets, segmenting the markets by type and providing historical and forecast market values. Porter’s and PESTEL analyses are included. The report canvasses the competitive scenario and profiled the top 10 market participants.
More in-demand market research studies by Grand View Research can be found at its page.